Clinical utilization of whole-body PET/MRI in childhood sarcoma. Pediatr Radiol 2021 Mar;51(3):471-479
Date
10/12/2020Pubmed ID
33040234DOI
10.1007/s00247-020-04834-7Scopus ID
2-s2.0-85092394975 (requires institutional sign-in at Scopus site) 3 CitationsAbstract
Hybrid positron emission tomography (PET)/magnetic resonance imaging (MRI) has emerged as a useful tool that combines the superior tissue contrast of MRI with the targeted functional imaging of PET. In the assessment of sarcomas in children, PET/MRI has the potential to serve as a single point of service, allowing superior anatomical imaging and evaluation of metabolic uptake during one imaging session. In this pictorial essay, we review our preliminary experience with PET/MRI in the evaluation of pediatric sarcoma. The limitations and contraindications of PET/MRI are also discussed.
Author List
Qi J, Thakrar PD, Browning MB, Vo N, Kumbhar SSAuthors
Jing Qi MD, PhD Associate Professor in the Radiology department at Medical College of WisconsinPooja Thakrar MD Associate Professor in the Radiology department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
ChildFluorodeoxyglucose F18
Humans
Magnetic Resonance Imaging
Positron-Emission Tomography
Radiopharmaceuticals
Sarcoma
Soft Tissue Neoplasms